BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guerra-ruiz A, Casafont F, Cobo M, Terã¡n A, de-la-Peña J, Estebanez A, Pons-romero F. Increased bactericidal/permeability increasing protein in patients with cirrhosis. Liver International 2010;30:94-101. [DOI: 10.1111/j.1478-3231.2009.02121.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Theprungsirikul J, Thaden JT, Wierzbicki RM, Burns AS, Skopelja-Gardner S, Fowler VG Jr, Winthrop KL, Martin IW, Rigby WFC. Low-Avidity Autoantibodies against Bactericidal/Permeability-Increasing Protein Occur in Gram-Negative and Gram-Positive Bacteremia. Infect Immun 2020;88:e00444-20. [PMID: 32747603 DOI: 10.1128/IAI.00444-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Agiasotelli D, Alexopoulou A, Vasilieva L, Hadziyannis E, Goukos D, Daikos GL, Dourakis SP. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis. Liver Int. 2017;37:576-582. [PMID: 27712029 DOI: 10.1111/liv.13264] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
3 Alexopoulou A, Agiasotelli D, Vasilieva LE, Dourakis SP. Bacterial translocation markers in liver cirrhosis. Ann Gastroenterol. 2017;30:486-497. [PMID: 28845103 DOI: 10.20524/aog.2017.0178] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
4 Ponziani FR, Zocco MA, Cerrito L, Gasbarrini A, Pompili M. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018;12:641-656. [PMID: 29806487 DOI: 10.1080/17474124.2018.1481747] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 14.0] [Reference Citation Analysis]
5 Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, Shi P. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am J Gastroenterol. 2013;108:1601-1611. [PMID: 23877352 DOI: 10.1038/ajg.2013.221] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 11.0] [Reference Citation Analysis]
6 Balakrishnan A, Marathe SA, Joglekar M, Chakravortty D. Bactericidal/permeability increasing protein: a multifaceted protein with functions beyond LPS neutralization. Innate Immun 2013;19:339-47. [PMID: 23160386 DOI: 10.1177/1753425912465098] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
7 Bruns T, Peter J, Hagel S, Herrmann A, Stallmach A. The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection. Clin Exp Immunol. 2011;164:346-356. [PMID: 21413941 DOI: 10.1111/j.1365-2249.2011.04373.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
8 Chen CZ, Ou CY, Wang RH, Lee CH, Lin CC, Chang HY, Hsiue TR. The role of bactericidal/permeability-increasing protein in men with chronic obstructive pulmonary disease. COPD 2012;9:197-202. [PMID: 22409502 DOI: 10.3109/15412555.2011.654143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]